GRI Bio Inc (GRI): Next-Year EPS Estimate 46.86%
As of 2026-06-04, GRI Bio Inc (GRI) has a next-year EPS growth estimate of 46.86%.
GRI was first flagged by our screen on 2026-06-01, when analyst consensus for its next-year EPS growth was revised from 46.05% to 46.86%. Current-year growth is projected at 96.08%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 46.86%
- EPS growth this year
- 96.08%
- EPS next quarter (est)
- -$1.20
- Last price
- $2.13
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 46.86% | 96.08% | -$1.20 | $2.13 |
| 2026-06-03 | 46.86% | 96.08% | -$1.20 | $2.01 |
| 2026-06-02 | 46.86% | 96.08% | -$1.20 | $2.01 |
| 2026-06-01 | 46.86% | 96.08% | -$1.20 | $2.07 |
| 2026-05-31 | 46.05% | 95.69% | -$1.35 | $2.06 |
| 2026-05-28 | 46.05% | 95.69% | -$1.35 | $2.10 |
| 2026-05-27 | 46.05% | 95.69% | -$1.35 | $2.10 |
| 2026-05-26 | 46.05% | 95.69% | -$1.35 | $2.04 |
| 2026-05-25 | 46.05% | 95.69% | -$1.35 | $2.06 |
| 2026-05-24 | 46.05% | 95.69% | -$1.35 | $2.06 |
| 2026-05-21 | 46.05% | 95.69% | -$1.35 | $2.20 |
| 2026-05-20 | 46.05% | 95.69% | -$1.35 | $2.20 |
| 2026-05-19 | 46.05% | 95.69% | -$1.35 | $2.23 |
| 2026-05-18 | 46.05% | 95.69% | -$1.35 | $2.14 |
| 2026-05-17 | 46.05% | 95.69% | -$1.35 | $2.03 |
| 2026-05-14 | 47.79% | 87.38% | -$3.74 | $2.15 |
| 2026-05-13 | 47.79% | 87.38% | -$3.74 | $2.27 |
| 2026-05-12 | 47.79% | 87.38% | -$3.74 | $2.28 |
| 2026-05-11 | 47.79% | 87.38% | -$3.74 | $2.26 |
| 2026-05-10 | 47.79% | 87.38% | -$3.74 | $2.24 |
| 2026-05-07 | 47.79% | 87.38% | -$3.74 | $2.25 |
| 2026-05-06 | 47.79% | 87.38% | -$3.74 | $2.36 |
| 2026-05-05 | 47.79% | 87.38% | -$3.74 | $2.34 |
| 2026-05-04 | 47.79% | 87.38% | -$3.74 | $2.26 |
| 2026-05-03 | 47.79% | 87.38% | -$3.74 | $2.18 |
| 2026-04-30 | 47.79% | 87.38% | -$3.74 | $2.18 |
| 2026-04-29 | 47.79% | 87.38% | -$3.74 | $2.23 |
| 2026-04-28 | 47.79% | 87.38% | -$3.74 | $2.36 |
| 2026-04-27 | 47.79% | 87.38% | -$3.74 | $2.38 |
| 2026-04-26 | 47.79% | 87.38% | -$3.74 | $2.32 |
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is GRI Bio Inc's next-year EPS growth estimate?▾
As of 2026-06-04, GRI Bio Inc (GRI) has a next-year EPS growth estimate of 46.86%, based on analyst consensus.
When was the latest EPS estimate revision for GRI?▾
The most recent revision occurred on 2026-06-01, when analysts adjusted the next-year EPS growth estimate from 46.05% to 46.86%.
What sector and industry does GRI Bio Inc belong to?▾
GRI Bio Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. GRI appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. GRI Bio Inc (GRI) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports